# Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/veliparib-with-first-line-chemotherapy-and-as-maintenance-therapy-in-ovarian/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Robert L. Coleman,Gini F. Fleming,Mark F. Brady,Elizabeth M. Swisher,Karina Dahl Steffensen,Michael Friedländer,Aikou Okamoto,Kathleen N. Moore,Noa Ben-Baruch,Theresa L. Werner,Noelle Cloven,Ana Oaknin,Paul DiSilvestro,Mark A. Morgan,Joo‐Hyun Nam,Charles A. Leath,Shibani Nicum,Andrea R. Hagemann,Ramey D. Littell,David Cella,Sally Baron‐Hay,Jesús García-Donás,Mika Mizuno,Katherine M. Bell‐McGuinn,Danielle Sullivan,Bruce Allen Bach,Sudipta Bhattacharya,Christine K. Ratajczak,Peter Ansell,Minh H. Dinh,Carol Aghajanian,Michael A. Bookman |
| Citations | 938 |
| DOI | 10.1056/nejmoa1909707 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1909707?articleTools=true |
| OpenAlex ID | https://openalex.org/W2976139792 |
| PMID | 31562800 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Robert L. Coleman](https://scholariq.org/researchers/robert-l-coleman/)
- [Michael Friedländer](https://scholariq.org/researchers/michael-friedlander/)
- [Paul DiSilvestro](https://scholariq.org/researchers/paul-disilvestro/)
- [David Cella](https://scholariq.org/researchers/david-cella/)
- [Carol Aghajanian](https://scholariq.org/researchers/carol-aghajanian/)
- [Elizabeth M. Swisher](https://scholariq.org/researchers/elizabeth-m-swisher/)

## Paper funders

- [AbbVie](https://scholariq.org/funders/abbvie/)
- [National Cancer Institute](https://scholariq.org/funders/national-cancer-institute/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.